{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:26:19Z","timestamp":1789608379778,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T00:00:00Z","timestamp":1530576000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Roche and the Virgo consortium"},{"name":"Dutch government","award":["FES0908"],"award-info":[{"award-number":["FES0908"]}]},{"name":"Region of Flanders through the Centre for Medical Innovation"},{"name":"Research Mandate of the Foundation Against Cancer Belgium","award":["2014-087"],"award-info":[{"award-number":["2014-087"]}]},{"name":"ZonMW VIDI","award":["91712329"],"award-info":[{"award-number":["91712329"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.antiviral.2018.06.015","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T19:10:22Z","timestamp":1530213022000},"page":"27-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["TLR7 polymorphism, sex and chronic HBV infection influence plasmacytoid DC maturation by TLR7 ligands"],"prefix":"10.1016","volume":"157","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7907-8315","authenticated-orcid":false,"given":"Sonja I.","family":"Buschow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula J.","family":"Biesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zwier M.A.","family":"Groothuismink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole S.","family":"Erler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0572-8741","authenticated-orcid":false,"given":"Thomas","family":"Vanwolleghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Najera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malika","family":"Ait-Goughoulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0934-6975","authenticated-orcid":false,"given":"Robert J.","family":"de Knegt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Boonstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Woltman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2018.06.015_bib1","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jmv.21893","article-title":"Toll-like receptor 7 rs179008\/Gln11Leu gene variants in chronic hepatitis C virus infection","volume":"82","author":"Askar","year":"2010","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2018.06.015_bib2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2018.06.015_bib3","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1172\/JCI26032","article-title":"Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions","volume":"115","author":"Beignon","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2018.06.015_bib4","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.4049\/jimmunol.177.4.2088","article-title":"TLR7 ligands induce higher IFN-alpha production in females","volume":"177","author":"Bergh\u00f6fer","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2018.06.015_bib5","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.jhep.2016.01.026","article-title":"Adaptive immunity in HBV infection","volume":"64","author":"Bertoletti","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2018.06.015_bib6","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/JVI.02844-06","article-title":"Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection","volume":"81","author":"Boni","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.06.015_bib7","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1053\/j.gastro.2012.07.014","article-title":"Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues","volume":"143","author":"Boni","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2018.06.015_bib8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3851\/IMP2023","article-title":"Potent immune activation in chronic hepatitis C patients upon administration of an oral inducer of endogenous interferons that acts via Toll-like receptor 7","volume":"17","author":"Boonstra","year":"2011","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2018.06.015_bib9","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/apt.12910","article-title":"Polymorphisms of HLA-DP are associated with response to peginterferon in Caucasian patients with chronic hepatitis B","volume":"40","author":"Brouwer","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.antiviral.2018.06.015_bib10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","article-title":"Molecular mechanism and function of CD40\/CD40L engagement in the immune system","volume":"229","author":"Elgueta","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.antiviral.2018.06.015_bib11","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/liv.13533","article-title":"Genetic variations in Toll-like receptors 7 and 8 modulate natural hepatitis C outcomes and liver disease progression","volume":"38","author":"Fakhir","year":"2018","journal-title":"Liver Int."},{"key":"10.1016\/j.antiviral.2018.06.015_bib12","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.4049\/jimmunol.145.10.3442","article-title":"Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection","volume":"145","author":"Ferrari","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2018.06.015_bib13","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1136\/gutjnl-2015-310239","article-title":"Sex-specific effects of TLR9 promoter variants on spontaneous clearance of HCV infection","volume":"66","author":"Fischer","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2018.06.015_bib14","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1182\/blood-2002-10-3063","article-title":"Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity","volume":"101","author":"Fonteneau","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2018.06.015_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1479-5876-12-129","article-title":"Tickling the TLR7 to cure viral hepatitis","volume":"12","author":"Funk","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.antiviral.2018.06.015_bib16","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.4049\/jimmunol.0802041","article-title":"Recall responses by helpless memory CD8+ T cells are restricted by the up-regulation of PD-1","volume":"182","author":"Fuse","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2018.06.015_bib17","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jhep.2015.02.037","article-title":"The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection","volume":"63","author":"Gane","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2018.06.015_bib18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0008-8749(02)00517-8","article-title":"Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod","volume":"218","author":"Gibson","year":"2002","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.antiviral.2018.06.015_bib19","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.196.Supp.124.17","article-title":"TLR7 responsiveness of human transitional B cells","volume":"196","author":"Giltiay","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2018.06.015_bib20","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.4049\/jimmunol.1501684","article-title":"Sex differences in plasmacytoid dendritic cell levels of IRF5 drive higher IFN-\u03b1 production in women","volume":"195","author":"Griesbeck","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2018.06.015_bib21","first-page":"65","article-title":"Board of the foundation of the Scandinavian journal of statistics a simple sequentially rejective multiple test procedure a simple sequentially rejective multiple test procedure","volume":"6","author":"Holm","year":"1979","journal-title":"Source Scand. J. Stat. Scand J Stat."},{"key":"10.1016\/j.antiviral.2018.06.015_bib22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.antiviral.2014.06.020","article-title":"Analysis of the transcriptome and immune function of monocytes during IFN\u03b1-based therapy in chronic HCV revealed induction of TLR7 responsiveness","volume":"109","author":"Hou","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.06.015_bib23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jim.2005.12.008","article-title":"A whole blood assay to assess peripheral blood dendritic cell function in response to Toll-like receptor stimulation","volume":"310","author":"Ida","year":"2006","journal-title":"J. Immunol. Meth."},{"key":"10.1016\/j.antiviral.2018.06.015_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003490","article-title":"CD40 activation rescues antiviral CD8+ T cells from PD-1-mediated exhaustion","volume":"9","author":"Isogawa","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2018.06.015_bib25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(05)17701-0","article-title":"Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial","volume":"365","author":"Janssen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2018.06.015_bib26","article-title":"Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally-suppressed patients with chronic hepatitis B","volume":"0","author":"Janssen","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2018.06.015_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1074-7613(03)00208-5","article-title":"Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6","volume":"19","author":"Jego","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2018.06.015_bib28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0168-8278(91)90074-L","article-title":"Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B","volume":"13","author":"Jung","year":"1991","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2018.06.015_bib29","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1002\/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H","article-title":"Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12","volume":"31","author":"Krug","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.antiviral.2018.06.015_bib30","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1053\/j.gastro.2013.02.003","article-title":"GS-9620, an oral agonist of toll-like Receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees","volume":"144","author":"Lanford","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2018.06.015_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139317","article-title":"ITPA polymorphisms are associated with hematological side effects during antiviral therapy for chronic HCV infection","volume":"10","author":"Maan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2018.06.015_bib32","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/hep.25879","article-title":"Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection","volume":"56","author":"Martinet","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2018.06.015_bib33","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1053\/j.gastro.2012.08.046","article-title":"Altered functions of plasmacytoid dendritic cells and reduced cytolytic activity of natural killer cells in patients with chronic HBV infection","volume":"143","author":"Martinet","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2018.06.015_bib34","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3389\/fimmu.2013.00372","article-title":"Human plasmacytoid dendritic cells: from molecules to intercellular communication network","volume":"4","author":"Mathan","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.antiviral.2018.06.015_bib35","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/nm.2004","article-title":"Sex differences in the Toll-like receptor\u2013mediated response of plasmacytoid dendritic cells to HIV-1","volume":"15","author":"Meier","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2018.06.015_bib36","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.jhep.2014.12.026","article-title":"Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B","volume":"62","author":"Menne","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2018.06.015_bib37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/QAD.0b013e32831fb540","article-title":"A frequent functional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression","volume":"23","author":"Oh","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2018.06.015_bib38","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1038\/ajg.2010.186","article-title":"A randomized trial of peginterferon \u03b1-2a with or without ribavirin for HBeAg-negative chronic hepatitis B","volume":"105","author":"Rijckborst","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2018.06.015_bib39","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.imlet.2014.04.005","article-title":"Association of single-nucleotide polymorphisms in TLR7 (Gln11Leu) and TLR9 (1635A\/G) with a higher CD4T cell count during HIV infection","volume":"160","author":"Said","year":"2014","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.antiviral.2018.06.015_bib40","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3389\/fimmu.2013.00387","article-title":"Targeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases","volume":"4","author":"Savva","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.antiviral.2018.06.015_bib41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jhep.2007.03.021","article-title":"A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection","volume":"47","author":"Schott","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2018.06.015_bib42","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jhep.2007.03.021","article-title":"Association of TLR7 single nucleotide polymorphisms with chronic HCV-infection and response to interferon-a-based therapy","volume":"42","author":"Schott","year":"2007","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2018.06.015_bib43","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s00262-010-0833-1","article-title":"Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy","volume":"59","author":"Schreibelt","year":"2010","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.antiviral.2018.06.015_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/science.aag3009","article-title":"Mapping the human DC lineage through the integration of high-dimensional techniques","volume":"356","author":"See","year":"2017","journal-title":"Science (80-. )"},{"key":"10.1016\/j.antiviral.2018.06.015_bib45","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood-2011-08-371831","article-title":"The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor \u03b1 signaling","volume":"119","author":"Seillet","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2018.06.015_bib46","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.4049\/jimmunol.1203312","article-title":"Estradiol promotes functional responses in inflammatory and steady-state dendritic cells through differential requirement for activation function-1 of estrogen receptor \u03b1","volume":"190","author":"Seillet","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2018.06.015_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aap8855","article-title":"TLR7 escapes X chromosome inactivation in immune cells","volume":"3","author":"Souyris","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.antiviral.2018.06.015_bib48","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.immuni.2010.11.020","article-title":"Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8+ T cell accrual","volume":"33","author":"Swiecki","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2018.06.015_bib49","doi-asserted-by":"crossref","first-page":"7431","DOI":"10.1073\/pnas.1002301107","article-title":"Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection","volume":"107","author":"Takahashi","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.antiviral.2018.06.015_bib50","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1182\/blood-2012-06-435644","article-title":"Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets","volume":"121","author":"Tel","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2018.06.015_bib51","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/eji.201444802","article-title":"BDCA3 expression is associated with high IFN-lambda production by CD34(+)-derived dendritic cells generated in the presence of GM-CSF, IL-4, and\/or TGF-beta","volume":"45","author":"van der Aa","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.antiviral.2018.06.015_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/science.aah4573","article-title":"Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors","volume":"356","author":"Villani","year":"2017","journal-title":"Science (80-. )"},{"key":"10.1016\/j.antiviral.2018.06.015_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015324","article-title":"Hepatitis b virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function","volume":"6","author":"Woltman","year":"2011","journal-title":"PLoS One"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217308409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217308409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T12:01:23Z","timestamp":1751716883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354217308409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":53,"alternative-id":["S0166354217308409"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.06.015","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TLR7 polymorphism, sex and chronic HBV infection influence plasmacytoid DC maturation by TLR7 ligands","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}